She will report to Teresa Graham, CEO of Roche Pharma, and become a member of the group’s pharma leadership team. “Ashley is a Roche and Genentech veteran, with a 20-year career that spans the ...

Roche has filled the open CEO position at Genentech with Alexander Hardy, a veteran of the subsidiary. The position has been open since previous CEO Bill Anderson left to head up Roche’s ...

including five years as treasurer at Genentech. Kathleen Sereda Glaub, a longtime Bay Area biotech executive who took two companies to billion-dollar buyouts, will take over the CEO duties at ...

Dr. Alexander brings two decades of biotechnology, biopharma, and medical leadership, most recently as SVP, Research & Development and Head of Boston Roche Innovation Center (BRIC), for ...

Roche’s Genentech is ending a partnership with Nykode Therapeutics that centered around a clinical-stage cancer vaccine ...

Total individual political contributions since 2008: $72,300 Biotech leader Art Levinson lobbied for Obama's healthcare reforms Art Levinson is the CEO of Genentech. Genentech is a biotech company.

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Tim Cook Named CEO and Jobs Elected Chairman of the Board CUPERTINO ... s most innovative and valuable technology company,” said Art Levinson, Chairman of Genentech, on behalf of Apple’s Board. “Steve ...

Today, we talk about how the autoimmune disease space is hotter than ever, see more gene therapy contraction, and the CEO of a generics giant talks about how elections affect industry. Investment ...

Key regulatory milestones and financial updates position Sangamo Therapeutics Inc (SGMO) for potential growth despite funding ...